Literature DB >> 5567559

Conversion of vitamin B 6 compounds to active forms in the red blood cell.

B B Anderson, C E Fulford-Jones, J A Child, M E Beard, C J Bateman.   

Abstract

In studies with pyridoxine and other B(6) compounds in blood, the active forms pyridoxal and pyridoxal phosphate were measured by differential assays using Lactobacillus casei. Red cell uptake of tritiated pyridoxine was also measured. A new metabolic pathway for conversion of pyridoxine to active forms was demonstrated in red cells. In vivo studies in normal subjects suggested that pyridoxine was taken up by red cells where it was converted to pyridoxal phosphate and then pyridoxal, followed by gradual release of a proportion of pyridoxal into plasma. In vitro incubation of pyridoxine with blood confirmed this observation. Increasing amounts of pyridoxine were taken up and converted as the amount added to blood was increased, and only very small numbers of red cells were needed to convert appreciable amounts. Conversion was markedly inhibited at temperatures lower than 37 degrees C, and stopped altogether at - 20 degrees C.Release of pyridoxal into plasma was always directly proportional to the amount of pyridoxal formed and to the volume of plasma present. That pyridoxal phosphate was not released into plasma was demonstrated in stored blood, for pyridoxine was converted mainly only as far as pyridoxal phosphate, probably due to inactivation of the phosphatase. Pyridoxal phosphate remained in the red cells. Pyridoxine was converted when incubated with washed red cells in saline or phosphate buffer suspension (0.08 M). In saline suspension, pyridoxal formed but was not released in the absence of plasma. In phosphate buffer suspension, pyridoxal phosphate was formed but was not changed to pyridoxal, probably due to inactivation of phosphatase by excess phosphate. Pyridoxamine was converted to active forms in red cells less efficiently. Pyridoxal entered red cells rapidly, equilibrating between plasma and cells within 1 min in the same ratio as pyridoxal formed inside red cells. Pyridoxal phosphate did not enter red cells in whole blood but did so readily in washed cells in saline.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5567559      PMCID: PMC292116          DOI: 10.1172/JCI106682

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Vitamin distribution in red blood cells, plasma, and other body fluids.

Authors:  H Baker; O Frank; A D Thomson; S Feingold
Journal:  Am J Clin Nutr       Date:  1969-11       Impact factor: 7.045

2.  Nicotinic acid-6-14C metabolism in man.

Authors:  K W Lee; D M Abelson; Y O Kwon
Journal:  Am J Clin Nutr       Date:  1968-03       Impact factor: 7.045

3.  Transport of vitamin B6 in human erythrocytes.

Authors:  K Yamada; M Tsuji
Journal:  J Vitaminol (Kyoto)       Date:  1968-12-10

4.  Vitamin B6 components in fresh and dried vegetables.

Authors:  M M Polansky
Journal:  J Am Diet Assoc       Date:  1969-02

5.  Determination of serum and blood pyridoxal phosphate concentrations with purified rabbit skeletal muscle apophosphorylase b.

Authors:  J D Hines; D S Love
Journal:  J Lab Clin Med       Date:  1969-02

6.  Vitamin B6 components in fruits and nuts.

Authors:  M M Polansky; E W Murphy
Journal:  J Am Diet Assoc       Date:  1966-02

7.  Effect of organic and inorganic phosphates on the oxygen equilibrium of human erythrocytes.

Authors:  A Chanutin; R R Curnish
Journal:  Arch Biochem Biophys       Date:  1967-07       Impact factor: 4.013

8.  Pyridoxal kinase activity in blood cells.

Authors:  A Hamfelt
Journal:  Clin Chim Acta       Date:  1967-04       Impact factor: 3.786

9.  The measurement of serum pyridoxal by a microbiological assay using Lactobacillus casei.

Authors:  B B Anderson; M B Peart; C E Fulford-Jones
Journal:  J Clin Pathol       Date:  1970-04       Impact factor: 3.411

10.  Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies.

Authors:  E Beutler
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

View more
  10 in total

1.  Vitamin B6 metabolism in chronic alcohol abuse The effect of ethanol oxidation on hepatic pyridoxal 5'-phosphate metabolism.

Authors:  R L Vech; L Lumeng; T K Li
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

2.  Vitamin B6 metabolism in chronic alcohol abuse. Pyridoxal phosphate levels in plasma and the effects of acetaldehyde on pyridoxal phosphate synthesis and degradation in human erythrocytes.

Authors:  L Lumeng; T K Li
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

3.  Primary acquired sideroblastic anaemia: response to treatment with pyridoxal-5-phosphate.

Authors:  D Y Mason; P M Emerson
Journal:  Br Med J       Date:  1973-02-17

4.  Restoration of the poor oxygen transport function of ACD-stored blood by pyridoxal 5'-phosphate.

Authors:  N Maeda; K Kon; M Sekiya; T Shiga
Journal:  Experientia       Date:  1979-09-15

5.  Evaluation of blood culture media for isolation of pyridoxal-dependent Streptococcus mitior (mitis).

Authors:  K C Gross; M P Houghton; R B Roberts
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

6.  Hydrolysis of pyridoxal-5'-phosphate in plasma in conditions with raised alkaline phosphate.

Authors:  B B Anderson; H O'Brien; G E Griffin; D L Mollin
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

7.  Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism.

Authors:  L Lumeng; A Lui; T K Li
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

8.  5'-deoxypyridoxal as a potential anti-sickling agent.

Authors:  R Benesch; R E Benesch; R Edalji; T Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

9.  Compartmentalization of pyridoxal-5'-phosphate during the acute phase of myocardial infarction.

Authors:  W J Vermaak; H C Barnard; E M Van Dalen; G M Potgieter; H Van Jaarsveld; S J Myburgh
Journal:  Klin Wochenschr       Date:  1988-05-16

10.  Methionine tumor starvation by erythrocyte-encapsulated methionine gamma-lyase activity controlled with per os vitamin B6.

Authors:  Fabien Gay; Karine Aguera; Karine Sénéchal; Angie Tainturier; Willy Berlier; Delphine Maucort-Boulch; Jérôme Honnorat; Françoise Horand; Yann Godfrin; Vanessa Bourgeaux
Journal:  Cancer Med       Date:  2017-05-23       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.